Monoclonal Antibodies Market - Forecasts From 2019 To 2024
The monoclonal antibodies market is projected to grow at a CAGR of 6.34% to reach US$131.766 billion by 2023, from US$91.122 billion in 2017. Monoclonal is a class of antibodies with indistinguishable posterity of a hybridoma, got by cell division from a solitary familial cell. The monoclonal antibodies market is driven by determined advancement in medicate improvement and revelation, expanding rates of interminable illnesses, positive administrative approaches, and high selection pace of restorative antibodies in developing economies.
Segmentation
The monoclonal antibodies market has been analyzed through the following segments:
By Indication
Inflammatory Disease
Cancer
Microbial Disease
Others
By Source
Humanized
Human
Chimeric
Murine
By Application
Diagnostic
Therapeutic
Others
By End-User
Hospitals & Clinics
Research Laboratories
By Geography
North America
USA
Canada
Mexico
Others
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Others
Middle East and Africa
Saudi Arabia
Israel
Others
Asia Pacific
China
Japan
South Korea
India
Others
